Shift to Everolimus (RAD) Kidney Sparing Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00420537
Recruitment Status : Terminated (A cluster of adverse events in everolimus arm was noted.)
First Posted : January 11, 2007
Last Update Posted : January 12, 2010
Information provided by:
University of Bologna